Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Platelet dysfunction in type 2 diabetes.

A I Vinik1, T Erbas, T S Park

  • 1Department of Medicine and Pathology/Anatomy/Neurobiology, the Strelitz Diabetes Research Institutes, Eastern Virginia Medical School, Norfolk, Virginia, USA. vinikai@evms.edu

Diabetes Care
|July 27, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Using systems mapping to understand the constraints and enablers of solutions to plastic pollution.

Journal of environmental management·2024
Same author

The environmental impact of nitrous oxide for labour analgesia.

Irish medical journal·2024
Same author

Osteosarcopenia in acromegaly: reduced muscle quality and increased vertebral fat deposition.

Journal of endocrinological investigation·2023
Same author

Acute respiratory infection symptoms and COVID-19 testing behaviour: results based on South Australian health surveys.

BMC public health·2021
Same author

Can’t Acopia, Won’t Acopia

Irish medical journal·2019
Same author

The efficacy of pregabalin for treating pain associated with diabetic peripheral neuropathy in subjects with type 1 or type 2 diabetes mellitus.

Current medical research and opinion·2018
Same journal

A Secular Increase in the Incidence of Islet Autoimmunity Among Colorado Children With Moderate-Risk HLA Genotypes.

Diabetes care·2026
Same journal

Clinical and Biochemical Recovery From Immune Checkpoint Inhibitor-Induced Diabetes With Seroconversion of GAD Antibodies.

Diabetes care·2026
Same journal

State Insulin Out-of-Pocket Cap Policies and Estimated Eligible Populations in the United States, 2019-2026.

Diabetes care·2026
Same journal

Genetic Determinants of Macronutrient Intake Are Associated With Specific Food Intake in Youth: A Cohort Study Across Childhood and Adolescence.

Diabetes care·2026
Same journal

A Novel Electronic Medical Record Search Method to Identify Patients With Ketosis-Prone Diabetes: Implications for Discovery of Atypical Diabetes.

Diabetes care·2026
Same journal

Real-Time Continuous Glucose Monitoring Among People With Type 2 Diabetes and End-Stage Kidney Failure Undergoing Maintenance Hemodialysis: A Randomized Clinical Trial.

Diabetes care·2026
See all related articles

Type 2 diabetes causes insulin resistance, leading to platelet dysfunction and vascular complications. Insulin normally restrains platelet hyperactivity, but its impaired action in diabetes promotes thrombosis and vascular events.

Area of Science:

  • Endocrinology
  • Vascular Biology
  • Hematology

Background:

  • Insulin resistance is a hallmark of type 2 diabetes, linked to microvascular and macrovascular complications.
  • Platelet dysfunction and abnormalities in the coagulation cascade contribute to vascular disease pathophysiology in diabetes.

Purpose of the Study:

  • To explore the role of hyperglycemia in microvascular deficiencies and platelet hyperactivity in diabetes.
  • To elucidate the impact of impaired insulin action on platelet function and vascular events.

Main Methods:

  • Review of existing literature on diabetes, insulin resistance, platelet function, and vascular complications.
  • Analysis of the interplay between hyperglycemia, endothelial function, and coagulation in type 2 diabetes.

Related Experiment Videos

Main Results:

  • Platelets in type 2 diabetes exhibit increased adhesion and aggregation due to reduced sensitivity to prostacyclin (PGI(2)) and nitric oxide (NO).
  • Insulin deficiency impairs the natural antagonism of platelet hyperactivity, exacerbating thrombosis risk.
  • Dysfunctional coagulation cascade, with elevated fibrinogen and plasminogen activator inhibitor 1, favors clot formation and hinders clot dissolution.

Conclusions:

  • Impaired insulin action in type 2 diabetes creates a prothrombotic state by promoting platelet hyperactivity and endothelial dysfunction.
  • Understanding these mechanisms is crucial for managing vascular complications in diabetic patients.